Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Clear cell ovarian cancer, Mucinous ovarian cancer, High-grade serous ovarian cancer, Platinum-sensitive ovarian cancer and the tag subtype-page.
Shares Clear cell ovarian cancer, Mucinous ovarian cancer, Letrozole (and other aromatase inhibitors), Bevacizumab and the tag subtype-page.
Shares RAINFOL-01 (Rina-S), Luveltamab tazevibulin, Rinatabart sesutecan, Letrozole (and other aromatase inhibitors) and the tag subtype-page.
Shares Topotecan, PD-L1, Bevacizumab, Gemcitabine and the tag subtype-page.
Shares Pegylated liposomal doxorubicin, Bevacizumab, Gemcitabine, Paclitaxel / nab-paclitaxel and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), PD-L1, Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Letrozole (and other aromatase inhibitors), Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Letrozole (and other aromatase inhibitors), Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.